Hydrophilic antibacterial degradable ureter stent and preparing method thereof
A ureteral stent and hydrophilic technology, applied in the direction of catheters, coatings, etc., can solve the problems of cytotoxicity, increased active oxygen content, and poor biocompatibility of implants, and achieve the conditions of preventing protein adhesion and modification Mild, low biotoxic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0039] Example 1
[0040] Such as figure 1 As shown, this embodiment provides a long-acting antibacterial and degradable ureteral stent tube. The specific preparation steps are as follows:
[0041] Step 1: Put the ureteral stent tube made of PGLA (910) into deionized water for ultrasonic cleaning for 15 minutes, and put it in an air laminar flow cabinet to dry; for later use.
[0042] Step 2: Put 0.2g of dopamine hydrochloride and 0.12g of tris(hydroxymethyl)aminomethane (Tris-HCL) into 100mL of deionized water, mix well, and titrate the pH to 8.5 with 0.01M NaOH and 0.01M HCL;
[0043] Step 3: Put the stent tube obtained in step 1 into the solution obtained in step 2, immerse it in an aerobic environment at 37°C for 24 hours and then take it out, ultrasonically clean in deionized water for 20 minutes and then dry;
[0044] Step 4: Dissolve the G3 polyamide-amine dendrimer in deionized water to prepare a 0.5wt% solution;
[0045] Step 5: Put the stent tube obtained in step 3 into the so...
Example Embodiment
[0050] Example 2
[0051] Such as figure 1 As shown, this embodiment provides a hydrophilic, antibacterial and degradable ureteral stent tube, and the specific preparation steps are as follows:
[0052] Step 1: Put the ureteral stent tube made of PGA into deionized water for ultrasonic cleaning for 15 minutes, and put it into the air laminar flow cabinet to dry; for later use.
[0053] Step 2: Put 0.2g of dopamine hydrochloride and 0.12g of tris(hydroxymethyl)aminomethane (Tris-HCL) into 100ml of deionized water, mix well, and titrate the pH to 8.5 with 0.01M NaOH and 0.01M HCL;
[0054] Step 3: Put the stent tube obtained in step 1 into the solution obtained in step 2, immerse it in an aerobic environment at 37°C for 24 hours and then take it out, ultrasonically clean for 20 minutes and then dry;
[0055] Step 4: Dissolve G1 polyamide-amine dendrimer in deionized water to prepare a 3wt% solution;
[0056] Step 5: Put the stent tube obtained in step 3 into the solution obtained in step ...
Example Embodiment
[0061] Example 3
[0062] Such as figure 1 As shown, this embodiment provides a hydrophilic, antibacterial and degradable ureteral stent tube, and the specific preparation steps are as follows:
[0063] Step 1: Put the ureteral stent tube made of PGLA (730) into deionized water for ultrasonic cleaning for 15 minutes, and put it in an air laminar flow cabinet to dry; for later use.
[0064] Step 2: Put 0.4g of dopamine hydrochloride and 0.12g of tris(hydroxymethyl)aminomethane (Tris-HCL) into 100ml of deionized water and mix well, and titrate the pH to 8.5 with 0.01M NaOH and 0.01M HCL;
[0065] Step 3: Put the stent tube obtained in step 1 into the solution obtained in step 2, immerse it in an aerobic environment at 37°C for 24 hours and then take it out, ultrasonically clean for 20 minutes and then dry;
[0066] Step 4: Dissolve the G5 polyamide-amine dendrimer in deionized water to prepare a 0.5wt% solution;
[0067] Step 5: Put the stent tube obtained in step 3 into the solution obta...
PUM
Property | Measurement | Unit |
---|---|---|
Water contact angle | aaaaa | aaaaa |
Water contact angle | aaaaa | aaaaa |
Water contact angle | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap